This site is new - feedback and suggestions welcome via GitHub issues.
Top 1d 2d 3d 7d 14d 30d
Show 10 20 50

#bispecific antibody  — top 20, last 30d

0 ℹ Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial. (nature.com) robot Nadeem O … Ghobrial IM Nature Medicine 2026-09-11 #multiple myeloma #immunotherapy #bispecific antibody #clinical trial #minimal residual disease